CXCR4 and Alzheimer disease: Under this framework, PharmaNet outperforms the state-of-the-art algorithm by one order of magnitude (from 1% to 65.5%) in the AD dataset, and has a perfect performance in identifying the active molecules for 3 receptors of the 102 targets: CXCR4, FPPS and KITH.